380 related articles for article (PubMed ID: 1703830)
1. [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
Henneberg-Quester KB; Luboldt W; Schaefer UW; Beelen DW; Quabeck K
Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830
[TBL] [Abstract][Full Text] [Related]
2. [ABO-major incompatible bone marrow transplantation. Experiences with a simple method for the preparation of erythrocyte-poor bone marrow].
Mayer G; Wernet D; Schneider W; Hanfland P
Beitr Infusionsther; 1990; 26():205-7. PubMed ID: 1703831
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
Rowley SD; Liang PS; Ulz L
Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
[TBL] [Abstract][Full Text] [Related]
4. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
5. Common problems in routine pre-transfusion testing.
Chandanayingyong D
Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):193-5. PubMed ID: 118531
[No Abstract] [Full Text] [Related]
6. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.
Bär BM; Van Dijk BA; Schattenberg A; de Man AJ; Kunst VA; de Witte T
Bone Marrow Transplant; 1995 Dec; 16(6):793-9. PubMed ID: 8750272
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
Tasaki T; Satoh S; Gotoh K; Fujii K; Sasaki S; Takadate J; Tachibana M; Ono Y; Ishida Y
Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
[TBL] [Abstract][Full Text] [Related]
8. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
9. What would Karl Landsteiner do? The ABO blood group and stem cell transplantation.
Heal JM; Liesveld JL; Phillips GL; Blumberg N
Bone Marrow Transplant; 2005 Nov; 36(9):747-55. PubMed ID: 16044140
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation with major ABO incompatibility. Experience of the Bone Marrow Transplantation Unit--Francisco Gentil Portuguese Institute of Oncology, Lisbon Centre.
Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
Acta Med Port; 1994 Dec; 7 Suppl 1():S21-4. PubMed ID: 7653275
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.
Curley C; Pillai E; Mudie K; Western R; Hutchins C; Durrant S; Kennedy GA
Transfusion; 2012 Feb; 52(2):291-7. PubMed ID: 21848968
[TBL] [Abstract][Full Text] [Related]
12. [Matching for ABO blood groups and HLA tissue types in transplantation with special reference to bone marrow transplantation].
Jakobsen BK; Dickmeiss E; Jacobsen N; Svejgaard A
Ugeskr Laeger; 2003 Dec; 165(50):4837-9. PubMed ID: 14716899
[No Abstract] [Full Text] [Related]
13. Immunohematologic problems arising from ABO incompatible bone marrow transplantation.
Sniecinski IJ; Petz LD; Oien L; Blume KG
Transplant Proc; 1987 Dec; 19(6):4609-11. PubMed ID: 3321631
[No Abstract] [Full Text] [Related]
14. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
[TBL] [Abstract][Full Text] [Related]
15. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
16. [Current problems of blood transfusion. Responsibility of the physician in transfusion].
Schönitzer D; Rosmanith P; Kilga-Nogler S
Infusionsther Klin Ernahr; 1985 Aug; 12(4):170-4. PubMed ID: 4066002
[TBL] [Abstract][Full Text] [Related]
17. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature.
Raimondi R; Soli M; Lamparelli T; Bacigalupo A; Arcese W; Belloni M; Rodeghiero F;
Bone Marrow Transplant; 2004 Aug; 34(4):321-9. PubMed ID: 15235580
[TBL] [Abstract][Full Text] [Related]
18. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow transplantation with major ABO incompatibility. Experience at the bone marrow transplantation unit of the Center of Lisbon at the IPOFG].
Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
Acta Med Port; 1993 Feb; 6(2):79-81. PubMed ID: 8488766
[TBL] [Abstract][Full Text] [Related]
20. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
Thomas L; Tuscany FL; Wilner GD
Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
